Case Studies & Evidence
See how IG-Smart supports regulated and high-consequence organisations with senior-led governance, independent assurance and practical outputs designed to stand up to procurement, board and regulatory scrutiny.
National programmes · enterprise assurance · retained specialist capability
Featured evidence
National strategy
National privacy-by-design framework · multiple national workstreams
National publications and programmes affect patient data at population scale; IG failures carry significant public-trust and regulatory consequences.
IG-Smart role: Strategic data-privacy and data-sharing advisory
Read Full Evidence: NHS EnglandEnterprise assurance
Nationwide supplier audit
AIG’s Head of Client Services EMEA: “the results exceeded our expectations… The audit not only identified areas of improvement…”Read Full Evidence: AIG
Retained specialist capability
Retained external DPO · EU & LATAM remit
The client's VP Legal & Compliance (EU and LATAM): “Knowledgeable and responsive… We are in safe hands.”Read Full Evidence: Glenmark Pharmaceuticals
Evidence library
2 of 15 case studies match
Glenmark Pharmaceuticals
Life Sciences / Pharmaceutical, Data Privacy & DPO, Retained / managed service
ProofRetained external DPO · EU & LATAM remit
A US-headquartered global pharmaceutical company with international operations
Life Sciences / Pharmaceutical, Data Privacy & DPO, Defined-scope assurance
ProofInternational data-transfer governance
What the evidence helps clients decide
The outlines show how IG-Smart structures typical outputs. They are not client documents.
Independent audit report · Supplier, IG or security audit
An independent view of how controls operate in practice, with rated findings and recommendations.
Representative IG-Smart structure — client information not shown
Prioritised improvement plan · Readiness for DSPT, ISO/IEC 27001 or audit
A sequenced plan that turns gaps into owned, evidenced actions.
Representative IG-Smart structure — client information not shown
Retained DPO advisory record · Outsourced or fractional DPO service
A running record of matters raised, advice given and the decisions taken.
Representative IG-Smart structure — client information not shown
Board assurance summary · Board, committee or executive reporting
An executive-level view of material findings, residual risk and decisions requiring accountable-owner attention.
Representative IG-Smart structure — client information not shown
Differentiation
Engagements are led by experienced practitioners with direct involvement in substantive advisory and assurance work, supported proportionately where appropriate.
Evidenced by:NHS EnglandCapgemini
Advice and assurance driven by evidence, requirements and risk rather than incentives to sell a technology platform.
Evidenced by:AIGA FTSE 100 organisation
Evidence supported through the published portfolio.
Evidenced by:NHS EnglandUCLGlenmark Pharmaceuticals
Evidence from managed and long-term client relationships.
Evidenced by:Glenmark PharmaceuticalsPAUL UK
Confidentiality & controlled disclosure
Some of IG-Smart's most sensitive engagements involve regulatory, operational, security, commercial or patient-safety information that cannot responsibly be published in full. Where necessary, examples are anonymised or withheld from public listing.
Additional evidence may sometimes be available, subject to:
Tell us the sector, service or procurement requirement you are assessing.
